Kay Seden

Summary

Affiliation: University of Liverpool
Country: UK

Publications

  1. ncbi Global patient safety and antiretroviral drug-drug interactions in the resource-limited setting
    Kay Seden
    NIHR Biomedical Research Centre, Royal Liverpool and Broadgreen University Hospital Trust, Liverpool, UK
    J Antimicrob Chemother 68:1-3. 2013
  2. ncbi Patients accessing HIV treatment via sexual health services: what are the risks of the dual case-note system?
    K Seden
    NIHR Biomedical Research Centre, Royal Liverpool and Broadgreen University Hospital Trust, Liverpool, UK
    Int J STD AIDS 23:99-104. 2012
  3. ncbi Grapefruit-drug interactions
    Kay Seden
    NIHR Biomedical Research Centre, Royal Liverpool and Broadgreen University Hospital Trust, Liverpool, UK
    Drugs 70:2373-407. 2010
  4. ncbi Directly acting antivirals for hepatitis C and antiretrovirals: potential for drug-drug interactions
    Kay Seden
    NIHR Biomedical Research Centre, Royal Liverpool and Broadgreen University Hospital Trust, Liverpool, UK
    Curr Opin HIV AIDS 6:514-26. 2011
  5. ncbi New directly acting antivirals for hepatitis C: potential for interaction with antiretrovirals
    Kay Seden
    NIHR Biomedical Research Centre, Royal Liverpool and Broadgreen University Hospitals Trust, and Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool, UK
    J Antimicrob Chemother 65:1079-85. 2010
  6. ncbi Antiretroviral drug interactions: often unrecognized, frequently unavoidable, sometimes unmanageable
    Kay Seden
    NIHR Biomedical Research Centre, Royal Liverpool and Broadgreen University Hospitals Trust, Liverpool, UK
    J Antimicrob Chemother 64:5-8. 2009

Detail Information

Publications6

  1. ncbi Global patient safety and antiretroviral drug-drug interactions in the resource-limited setting
    Kay Seden
    NIHR Biomedical Research Centre, Royal Liverpool and Broadgreen University Hospital Trust, Liverpool, UK
    J Antimicrob Chemother 68:1-3. 2013
    ....
  2. ncbi Patients accessing HIV treatment via sexual health services: what are the risks of the dual case-note system?
    K Seden
    NIHR Biomedical Research Centre, Royal Liverpool and Broadgreen University Hospital Trust, Liverpool, UK
    Int J STD AIDS 23:99-104. 2012
    ..We recommend that hospitals that continue to operate this system urgently consider amalgamation of HIV care records into hospital case sheets, in line with current national standards...
  3. ncbi Grapefruit-drug interactions
    Kay Seden
    NIHR Biomedical Research Centre, Royal Liverpool and Broadgreen University Hospital Trust, Liverpool, UK
    Drugs 70:2373-407. 2010
    ..The aim of this review is to outline the mechanisms of grapefruit-drug interactions and present a comprehensive summary of those agents affected and whether they are likely to be of clinical relevance...
  4. ncbi Directly acting antivirals for hepatitis C and antiretrovirals: potential for drug-drug interactions
    Kay Seden
    NIHR Biomedical Research Centre, Royal Liverpool and Broadgreen University Hospital Trust, Liverpool, UK
    Curr Opin HIV AIDS 6:514-26. 2011
    ..Potential for DDIs with the DAAs in clinical development and the mechanisms of interaction are also discussed...
  5. ncbi New directly acting antivirals for hepatitis C: potential for interaction with antiretrovirals
    Kay Seden
    NIHR Biomedical Research Centre, Royal Liverpool and Broadgreen University Hospitals Trust, and Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool, UK
    J Antimicrob Chemother 65:1079-85. 2010
    ..Therapeutic drug monitoring is likely to play a role in the clinical management of such interactions...
  6. ncbi Antiretroviral drug interactions: often unrecognized, frequently unavoidable, sometimes unmanageable
    Kay Seden
    NIHR Biomedical Research Centre, Royal Liverpool and Broadgreen University Hospitals Trust, Liverpool, UK
    J Antimicrob Chemother 64:5-8. 2009
    ....